LINC00355 and breast carcinoma: Taken together, we provide evidence that LINC00355 functions by binding to the MENIN protein, which decreases its occupancy at the promoter of CDKN1B, decreasing protein levels of p27Kip, increasing proliferation, and cellular invasion in late-stage relapse breast cancer models (Fig. 6).